Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk

Journal of Internal Medicine

Volumn 265, Issue 2, 2009, Pages 174-192

  Spinazzola, A ^a   Zeviani, M ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Mitochondrial disorders; Mitochondrial DNA; mtDNA depletion; mtDNA multiple deletions; Oxidative phosphorylation

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA;

ALPERS DISEASE; AUTOSOMAL RECESSIVE DISORDER; CELL NUCLEUS; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPLICATION; ENCEPHALOMYOPATHY; EPILEPSY; EXPERIMENTAL MODEL; FLY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MNGIE SYNDROME; MYOPATHY LACTIC ACIDOSIS SIDEROBLASTIC ANAEMIA SYNDROME; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY CHAIN; SACCHAROMYCES CEREVISIAE; SENSORY ATAXIC NEUROPATHY DYSARTHRIA AND OPHTHALMOPARESIS; SPINOCEREBELLAR DEGENERATION; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; GENE DELETION; HUMANS; MICE; MITOCHONDRIAL DISEASES; MUTATION; OXIDATIVE PHOSPHORYLATION;

EID: 58149333245     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.02059.x     Document Type: Conference Paper

References (110)

1. Calvo S, Jain M, Xie X et al. Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 2006 38 : 576 82.
2. Contamine V, Picard M. Maintenance and integrity of the mitochondrial genome: a plethora of nuclear genes in the budding yeast. Microbiol Mol Biol Rev 2000 64 : 281 315.
3. Clayton DA. Vertebrate mitochondrial DNA - a circle of surprises. Exp Cell Res 2000 255 : 4 9.
4. Holt IJ, Lorimer HE, Jacobs HT. Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA. Cell 2000 100 : 515 24.
5. Zeviani M, Servidei S, Gellera C et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D loop region. Nature 1989 339 : 309 11.
6. Servidei S, Zeviani M, Manfredi G et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology 1991 41 : 1053 9.
7. Hirano M, Marti R, Ferreiro-Barros C et al. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Dev Biol 2001 12 : 417 27.
8. Amati-Bonneau P, Valentino ML, Reynier P et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008 131 : 338 51.
9. Hudson G, Amati-Bonneau P, Blakely EL et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008 13 : 329 37.
10. Yuzaki M, Ohkoshi N, Kanazawa I et al. Multiple deletions in mitochondrial DNA at direct repeats of non-D-loop regions in cases of familial mitochondrial myopathy. Biochem Biophys Res Commun 1989 164 : 1352 7.
11. Mizusawa H, Watanabe M, Kanazawa I et al. Familial mitochondrial myopathy associated with peripheral neuropathy: partial deficiencies of complex 1 and complex 4. J Neurol Sci 1988 86 : 171 84.
12. Lamantea E, Tiranti V, Bordoni A et al. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002 52 : 211 9.
13. Agostino A, Valletta L, Chinnery PF et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003 60 : 1354 6.
14. Hirano M, Silvestri G, Blake DM et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994 44 : 721 7.
15. Giordano C, Sebastiani M, Plazzi G et al. Mitochondrialneurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology 2006 130 : 893 901.
16. Marti R, Verschuuren JJ, Buchman A, Hirano I, Tadesse S. Late- onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol 2005 58 : 649 52.
17. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005 354 : 162 8.
18. Moraes CT, Shanske S, Tritschler HJ et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991 48 : 492 501.
19. Tritschler HJ, Andreetta F, Moraes CT et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 1992 42 : 209 17.
20. Galbiati S, Bordoni A, Papadimitriou D. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol 2006 34 : 177 85.
21. Oskoui M, Davidzon G, Pascual J et al. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 2006 63 : 1122 6.
22. Bourdon A, Minai L, Serre V et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007 39 : 776 80.
23. Bornstein B, Area E, Flanigan KM et al. Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene. Neuromuscul Disord 2008 18 : 453 9.
24. Elpeleg O, Miller C, Hershkovitz E et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 2005 76 : 1081 6.
25. Carrozzo R, Dionisi-Vici C, Steuerwald U et al. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 2007 13 : 862 74.
26. Ostergaard E, Hansen FJ, Sorensen N et al. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 2007 130 : 853 61.
27. Ostergaard E, Christensen E, Kristensen E et al. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 2007 81 : 383 7.
28. Vu TH, Tanji K, Holve SA, Bonilla E et al. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome? Hepatology 2001 34 : 116 20.
29. Kaukonen J, Juselius JK, Tiranti V et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000 289 : 782 5.
30. Spelbrink JN, Li FY, Tiranti V et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001 28 : 223 31.
31. Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001 28 : 211 2.
32. Palmieri L, Alberio S, Pisano I, Lodi T et al. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet 2005 14 : 3079 88.
33. Galassi G, Lamantea E, Invernizzi F et al. Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy. Neuromuscul Disord 2008 18 : 465 70.
34. Nikali K, Suomalainen A, Saharinen J et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005 14 : 2981 90.
35. Hakonen AH, Goffart S, Marjavaara S, Paetau A et al. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 2008 17 : 3822 35. [Epub ahead of print].
36. Luoma P, Melberg A, Rinne JO et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004 364 : 875 82.
37. Filosto M, Mancuso M, Nishigaki Y et al. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol 2003 60 : 1279 84.
38. Invernizzi F, Varanese S, Thomas A et al. Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. Neuromuscul Disord 2008 18 : 460 4.
39. Van Goethem G, Martin JJ, Dermaut B et al. POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003 13 : 133 42.
40. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004 55 : 706 12.
41. Davidzon G, Mancuso M, Ferraris S et al. POLG mutations and Alpers syndrome. Ann Neurol 2005 57 : 921 3.
42. Ferrari G, Lamantea E, Donati A et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005 128 : 723 31.
43. Van Goethem G, Luoma P, Rantamaki M et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004 63 : 1251 7.
44. Winterthun S, Ferrari G, He L et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 2005 64 : 1204 8.
45. Horvath R, Hudson G, Ferrari G, Futterer N et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006 129 : 1674 84.
46. Longley MJ, Clark S, Yu Wai Man C et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006 78 : 1026 34.
47. Duvezin-Caubet S, Jagasia R, Wagener J et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 2006 281 : 37972 9.
48. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 2004 15 : 5001 11.
49. Alexander C, Votruba M, Pesch UE et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000 26 : 211 5.
50. Delettre C, Lenaers G, Griffoin JM et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000 26 : 207 10.
51. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Scand 1959 37 : 1 146.
52. Zeviani M. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 2008 131 : 314 7.
53. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999 283 : 689 92.
54. Spinazzola A, Marti R, Nishino I et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002 277 : 4128 33.
55. Marti R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 2004 50 : 120 4.
56. Ferraro P, Pontarin G, Crocco L et al. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 2005 280 : 24472 80.
57. Pontarin G, Ferraro P, Valentino ML et al. Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 2006 281 : 22720 8.
58. Nishigaki Y, Marti R, Copeland WC, Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 2003 111 : 1913 2.
59. Song S, Wheeler LJ, Mathews CK. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 2003 278 : 43893 6.
60. Yavuz H, Ozel A, Christensen M, Christensen E et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007 64 : 435 8.
61. Hirano M, Martí R, Casali C, Tadesse S et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006 67 : 1458 60.
62. Lara MC, Weiss B, Illa I, Madoz P et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006 67 : 1461 3.
63. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001 29 : 342 4.
64. Sarzi E, Goffart S, Serre V et al. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 2007 62 : 579 87.
65. Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lonnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007 130 : 3032 40.
66. Mandel H, Szargel R, Labay V et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001 29 : 337 41.
67. Salviati L, Sacconi S, Mancuso M, Otaegui D et al. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 2002 52 : 311 6.
68. Tadiboyina VT, Rupar A, Atkison P et al. Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria. Am J Med Genet 2005 135A : 289 91.
69. Spinazzola A, Viscomi C, Fernandez-Vizarra E et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006 38 : 570 5.
70. Wong LJ, Brunetti-Pierri N, Zhang Q, Yazigi N et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 2007 46 : 1218 27.
71. Spinazzola A, Santer R, Akman OH et al. Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations. Arch Neurol 2008 65 : 1108 13.
72. Karadimas CL, Vu TH, Holve SA et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 2006 79 : 544 8.
73. Spinazzola A, Massa V, Hirano M, Zeviani M. Lack of founder effect for an identical mtDNA depletion syndrome (MDS)-associated MPV17 mutation shared by Navajos and Italians. Neuromuscul Disord 2008 18 : 315 8.
74. Moslemi AR, Melberg A, Holme E, Oldfors A. Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol 1996 40 : 707 13.
75. Kajander OA, Rovio AT, Majamaa K et al. Human mtDNA sublimons resemble rearranged mitochondrial genomes found in pathological states. Hum Mol Genet 2000 9 : 2821 35.
76. Graziewicz MA, Longley MJ, Bienstock RJ, Zeviani M, Copeland WC. Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia. Nat Struct Mol Biol 2004 11 : 770 6.
77. Ashley N, Adams S, Slama A et al. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. Hum Mol Genet 2007 16 : 1400 11.
78. Wang X, Salinas K, Zuo X, Kucejova B, Chen XJ. Dominant membrane uncoupling by mutant adenine nucleotide translocase in mitochondrial diseases. Hum Mol Genet 2008 17 : 4036 44 epub ahead of print HT, Turnbull DM. Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 2005 21 : 312 4 (Review).
79. Ma L, Spremulli LL. Cloning and sequence analysis of the human mitochondrial translational initiation factor 2 cDNA. J Biol Chem 1995 270 : 1859 65.
80. Koc EC, Spremulli LL. Identification of mammalian mitochondrial translational initiation factor 3 and examination of its role in initiation complex formation with natural mRNAs. J Biol Chem 2002 277 : 35541 9.
81. Ling M, Merante F, Chen HS, Duff C, Duncan AM, Robinson BH. The human mitochondrial elongation factor tu (EF-Tu) gene: cDNA sequence, genomic localization, genomic structure, and identification of a pseudogene. Gene 1997 197 : 325 36.
82. Xin H, Woriax V, Burkhart W, Spremulli LL. Cloning and expression of mitochondrial translational elongation factor Ts from bovine and human liver. J Biol Chem 1995 270 : 17243 9.
83. Gao J, Yu L, Zhang P et al. Cloning and characterization of human and mouse mitochondrial elongation factor G, GFM and Gfm, and mapping of GFM to human chromosome 3q25.1-q26.2. Genomics 2001 74 : 109 14.
84. Zhang Y, Spremulli LL. Identification and cloning of human mitochondrial translational release factor 1 and the ribosome recycling factor. Biochim Biophys Acta 1998 1443 : 245 50.
85. Miller C, Saada A, Shaul N et al. Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 2004 56 : 734 8.
86. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004 74 : 1303 8.
87. Zeharia A, Fischel-Ghodsian N, Casas K et al. Mitochondrial myopathy, sideroblastic anemia, and lactic acidosis: an autosomal recessive syndrome in Persian Jews caused by a mutation in the PUS1 gene. J Child Neurol 2005 20 : 449 52.
88. Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M. Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anemia (MLASA). J Med Genet 2006 44 : 173 80.
89. Coenen MJ, Antonicka H, Ugalde C et al. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 2004 351 : 2080 6.
90. Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA. The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 2006 15 : 1835 46.
91. Valente L, Tiranti V, Marsano RM et al. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet 2007 80 : 44 58.
92. Smeitink JA, Elpeleg O, Antonicka H et al. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 2006 79 : 869 77.
93. Scheper GC, van der Klok T, van Andel RJ et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007 39 : 534 9.
94. Edvardson S, Shaag A, Kolesnikova O et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 2007 81 : 857 62.
95. Saada A, Shaag A, Arnon S et al. Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. Med Genet 2007 44 : 784 6.
96. Fontanesi F, Palmieri L, Scarcia P et al. Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability. Hum Mol Genet 2004 13 : 923 34.
97. Baruffini E, Ferrero I, Foury F. Mitochondrial DNA defects in Saccharomyces cerevisiae caused by functional interactions between DNA polymerase gamma mutations associated with disease in human. Biochim Biophys Acta 2007 1772 : 1225 35.
98. Stuart GR, Santos JH, Strand MK, Van Houten B, Copeland WC. Mitochondrial and nuclear DNA defects in Saccharomyces cerevisiae with mutations in DNA polymerase gamma associated with progressive external ophthalmoplegia. Hum Mol Genet 2006 15 : 363 74.
99. Baruffini E, Lodi T, Dallabona C, Puglisi A, Zeviani M, Ferrero I. Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans. Hum Mol Genet 2006 15 : 2846 55.
100. Toivonen JM, O'Dell KM, Petit N et al. Technical knockout, a Drosophila model of mitochondrial deafness. Genetics 2001 159 : 241 54.
101. Iyengar B, Roote J, Campos AR. The tamas gene, identified as a mutation that disrupts larval behavior in Drosophila melanogaster, codes for the mitochondrial DNA polymerase catalytic subunit (DNApol-gamma125). Genetics 1999 153 : 1809 24.
102. Lefai E, Calleja M, Ruiz de Mena I, Lagina AT III., Kaguni LS, Garesse R. Overexpression of the catalytic subunit of DNA polymerase gamma results in depletion of mitochondrial DNA in Drosophila melanogaster. Mol Gen Genet 2000 264 : 37 46.
103. Iyengar B, Luo N, Farr CL, Kaguni LS, Campos AR. The accessory subunit of DNA polymerase gamma is essential for mitochondrial DNA maintenance and development in Drosophila melanogaster. Proc Natl Acad Sci USA 2002 99 : 4483 8.
104. Trifunovic A, Wredenberg A, Falkenberg M et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004 429 : 417 23.
105. Tyynismaa H, Mjosund KP, Wanrooij S et al. Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci USA 2005 102 : 17687 92.
106. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997 1 : 226 34.
107. Zhou X, Solaroli N, Bjerke M et al. Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum Mol Genet 2008 17 : 2329 35.
108. Akman HO, Dorado B, López LC et al. Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. Hum Mol Genet 2008 17 : 2433 40.
109. Kimura T, Takeda S, Sagiya Y, Gotoh M, Nakamura Y, Arakawa H. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools. Nat Genet 2003 34 : 440 5.
110. Viscomi C, Spinazzola A, Maggioni M et al. Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice. Hum Mol Genet 2008 [Epub ahead of print], September.